B-CELL in Chinese translation

• b细胞

Examples of using B-cell in English and their translations into Chinese

To help diagnose a B-cell lymphoma;
帮助诊断B细胞淋巴瘤;

B-cell NHL is the more common variety.
B细胞NHL是较为常见的品种。

Lamin B1 regulates somatic mutations and progression of B-cell malignancies.
LAMINB1调节体细胞突变和B细胞恶性肿瘤的进展。

When a doctor thinks that you may have a B-cell lymphoma;
当保健医生认为你“可以具有B细胞淋巴瘤;

D81.2 Severe combined immunodeficiency w/ low or normal B-cell numbers.
D81.2伴有B细胞数量低下或正常的严重组合免疫缺陷［SCID］.

First of all, prediction of B-cell epitopes is still unreliable for both linear and conformational B-cell epitopes.
首先，对于线性和构象B细胞表位，B细胞表位的预测仍然是不可靠的。

BTK is a validated molecular target found across numerous B-cell leukemias and lymphomas.
BTK是在众多B细胞白血病和淋巴瘤中发现的一种有效的分子靶点。

ALL can be of either T- or B-cell origin, with the B-cell type being the most common.
ALL可以是T-细胞或B细胞来源，B细胞是最常见的。

For patients with CD19-positive B-cell leukemia, CAR-T cells can be very effective.
对于CD19阳性的B细胞白血病患者，CAR-T细胞可以起到很好的疗效。

TNFRSF17 promotes b-cell survival and plays a role in the regulation of humoral immunity.
TNFRSF17促进B细胞存活，在调节体液免疫中发挥作用。

Currently, T-cell epitope prediction is more advanced and reliable than that of B-cell prediction.
目前，T细胞表位预测比B细胞预测更先进和可靠。

B-cell maturation antigen(BCMA) is a protein that is highly expressed on myeloma cells.
B细胞成熟抗原（BCMA）是一种在骨髓瘤细胞上高度表达的蛋白质。

Pooled safety data from six ongoing monotherapy studies in patients with B-cell malignancies; and.
六项作为单药治疗B细胞恶性肿瘤患者的临床试验安全性数据汇总分析；以及.

In the United States, B-cell non-Hodgkin lymphomas are much more common than T-cell and NK-cell lymphomas.
在美国，B细胞非霍奇金淋巴瘤是远远超过T细胞和NK细胞淋巴瘤更常见。

Zanubrutinib tolerability was generally consistent with previous reports of zanubrutinib treatment in patients with various B-cell malignancies.
Zanubrutinib的总体耐受性与先前报道的治疗患有多种B细胞恶性肿瘤的患者的数据一致。

When a healthcare practitioner thinks that you may have a B-cell lymphoma;
当保健医生认为你“可以具有B细胞淋巴瘤;

Mediastinal B-cell lymphoma(lymphomation. org).
纵隔B淋巴细胞瘤(lymphomation.org)（英文）.

ML has also been applied to predict conformational B-cell epitopes in 3D-structures.
ML还已用于预测3D结构中的构象B细胞表位。

In this setting, B-cell expansions are polyclonal, with each clone containing relatively few cells and no one clone predominating.
在此设置，B细胞扩张是多克隆的，用含有克隆relativamente少数细胞每个容器，而不是一个克隆者为主。

It's been approved to treat two types of cancer: B-cell precursor acute lymphoblastic leukemia(ALL) and diffuse large B-cell lymphoma.
它已被批准用于治疗两种类型的癌症：B细胞前体急性淋巴细胞白血病（ALL）和弥漫性大B细胞淋巴瘤。